Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
A multiple linear regression analysis was conducted to determine the effects of the APOE genotype on the relationships between morphometric features and neuropsychiatric symptoms in SCD.
|
31159873 |
2019 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
As few studies have examined the relationship between the apolipoprotein E (APOE) gene and clinical outcomes after military-related traumatic brain injury (TBI), we aimed to determine whether the ε4 allele of the APOE gene influences neuropsychiatric symptoms in veterans with a history of mild-to-moderate TBI.
|
29463164 |
2018 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
The results show that in Thai individuals, the presence of ApoE4 allele is accompanied by a multifarious decline in neurocognitive functions and behavioral features and that ApoE3 may convey protection against neuropsychiatric symptoms and a decline in social skills.
|
29307083 |
2018 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
It was hypothesized that neuropsychiatric symptoms and the apolipoprotein E genotype increase the likelihood of Alzheimer's disease development.
|
27111252 |
2017 |
Behavioral and psychological symptoms of dementia
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Considering the role of apolipoprotein E in the life cycle of the virus, the findings shed interesting new light upon possible pathomechanisms behind the development of neuropsychiatric symptoms in hepatitis C infection.
|
26306786 |
2016 |
Behavioral and psychological symptoms of dementia
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The interaction between gender and ApoE ε4 status should be considered in studies on neuropsychiatric symptoms of AD.
|
26538817 |
2015 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
The differences in neuropsychiatric symptoms between the two groups were most pronounced in patients with the APOE ε4 allele, suggesting that neuropsychiatric symptoms in AD may be influenced by the APOE genotype.
|
25322926 |
2015 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
This study analyzed the effects of the BChE and ApoE genotypes on the cortical thickness of patients with AD and examined how these genotypes affect the neuropsychiatric symptoms of AD.
|
24479631 |
2014 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Sleep length and architecture are potential markers of progressive cognitive impairment, while neuropsychiatric symptoms and APOE4- haplotypes have been associated with more sleep complaints in patients with dementia due to Alzheimer's disease (AD).
|
25194823 |
2014 |
Behavioral and psychological symptoms of dementia
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The impact of APOE status on relationship of biomarkers of vascular risk and systemic inflammation to neuropsychiatric symptoms in Alzheimer's disease.
|
24577461 |
2014 |
Behavioral and psychological symptoms of dementia
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
After adjusting for age and education, neuropsychiatric symptoms and APOE ε4 were independently associated with CIND and dementia status at baseline (compared with cognitively normal).
|
22927174 |
2013 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.
|
21763789 |
2012 |
Behavioral and psychological symptoms of dementia
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
This study investigates the association between APOE and neuropsychiatric symptoms in a large sample of clinically well-characterized subjects with probable AD (n=790) who were systematically evaluated using the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Behavioral Rating Scale for Dementia (BRSD).
|
23270420 |
2012 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Apolipoprotein E polymorphism and behavioral and psychological symptoms of dementia in patients with Alzheimer disease.
|
21617520 |
2012 |
Behavioral and psychological symptoms of dementia
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Apolipoprotein E (APOE) ε4 status may modify the effects of sex hormones on neuropsychiatric symptoms.
|
22398564 |
2012 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
|
21905100 |
2011 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Neuropsychiatric symptoms and the APOE genotype in Alzheimer's disease.
|
19590821 |
2009 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
There have been inconclusive results to date on the association between the Apolipoprotein E (ApoE) genotype and neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD).
|
16390371 |
2006 |
Behavioral and psychological symptoms of dementia
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
A highly statistically significant association was seen between APOE genotypes and interferon-induced neuropsychiatric symptoms.
|
14709760 |
2004 |